Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical BMT with RIC and Post-transplant Cyclophosphamide for Lymphomas
NCT02049580Phase 2Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Jul 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in lymphoma, Hodgkin lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), chronic lymphocytic leukemia (CLL), sponsored by Humanitas Research Hospital. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
lymphomaHodgkin lymphoma (HL)diffuse large B-cell lymphoma (DLBCL)peripheral T-cell lymphoma (PTCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02049580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049580.